Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

Neck Injury Prediction Rule Could Decrease Imaging Exposure in Children, Study Finds
Healthcare & PharmaceuticalCompany Update

Neck Injury Prediction Rule Could Decrease Imaging Exposure in Children, Study Finds

June 6, 2024 10:30 AM

COLUMBUS, OH / ACCESSWIRE / June 6, 2024 / Cervical spine injuries in children are relatively rare but can have serious consequences, like paralysis. The standard method for detecting these injuries involves X-rays and computed tomography (CT) scans, which expose children to radiation and may pose long-term health risks. In a study published June 4 in The Lancet Child & Adolescent Health, researchers from the Pediatric Emergency Care Applied...

Read more
Lab Week 2024 - Lisa Szeto-Tay
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Lab Week 2024 - Lisa Szeto-Tay

June 6, 2024 10:15 AM

NORTHAMPTON, MA / ACCESSWIRE / June 6, 2024 / Quest DiagnosticsQuest colleagues from coast-to-coast marked Lab Week 2024 with a week full of activities to celebrate our medical laboratory professionals and pathologists. As part of the celebration, we also featured highlights of the professional journeys of Quest colleagues from across the country.---From Phlebotomist to Group Lead, Medical Laboratory Scientist10 years at QuestNorth Region -...

Read more
Board-Certified and Highly Accomplished Lasik Surgeon Now Treating Patients at Lasikplus Houston
Healthcare & PharmaceuticalCompany Update

Board-Certified and Highly Accomplished Lasik Surgeon Now Treating Patients at Lasikplus Houston

June 6, 2024 10:00 AM

HOUSTON, TX / ACCESSWIRE / June 6, 2024 / LASIK eye surgeon and Ophthalmology Residency Program Director of the San Antonio Uniformed Services Health Education Dr. Gary Legault is now treating patients at the LasikPlus River Oaks Vision Center located at 3700 Buffalo Speedway, Houston, Texas. Dr. Legault is renowned for his exceptional skills in laser refractive surgery, including LASIK and PRK. Dr. Legault has been performing LASIK since...

Read more
Lifeskills South Florida Expands Mental Health and Addiction Treatment Services to Orlando, Florida
Healthcare & PharmaceuticalCompany Update

Lifeskills South Florida Expands Mental Health and Addiction Treatment Services to Orlando, Florida

June 6, 2024 9:30 AM

BRENTWOOD, TN / ACCESSWIRE / June 6, 2024 / Odyssey Behavioral Healthcare, a leading provider of mental health, addiction, and eating disorder treatment, is proud to announce Lifeskills South Florida's expansion of mental health and addiction treatment services into Central Florida. The Orlando location will provide residential and outpatient services that specialize in treating adults with complex psychiatric and substance use disorders....

Read more
Biotricity Provides Year-End Guidance with Expectations to Meet Analyst Revenue Target and Beating Loss and Margin Targets
Healthcare & PharmaceuticalCompany Update

Biotricity Provides Year-End Guidance with Expectations to Meet Analyst Revenue Target and Beating Loss and Margin Targets

June 6, 2024 9:15 AM

Company expects Loss from Operations to decrease by over 40% YoY and Margin Improvement by over 10% YoYREDWOOD CITY, CA / ACCESSWIRE / June 6, 2024 / Biotricity Inc. (NASDAQ:BTCY), a leading Technology-as-a-Service (TaaS) company dedicated to disrupting the healthcare industry with cutting-edge medical and consumer diagnostic solutions, is excited to provide guidance for its upcoming Year-End Results. Biotricity announces expectations to meet...

Read more
DirectTrust(R) and Digital Therapeutics Alliance Announce Partnership to Provide Accreditation for Digital Therapeutics Industry
Healthcare & PharmaceuticalPartnerships

DirectTrust(R) and Digital Therapeutics Alliance Announce Partnership to Provide Accreditation for Digital Therapeutics Industry

June 6, 2024 9:00 AM

WASHINGTON, DC / ACCESSWIRE / June 6, 2024 / DirectTrust®, a non-profit healthcare industry alliance focused on furthering trust in healthcare data exchange through standards, accreditation, and other services, and Digital Therapeutics Alliance (DTA) today announced a collaborative partnership that will provide accreditation for efficacy, data privacy and security for digital therapeutics applications and platforms (DTx).Through this strategic...

Read more
Cloud DX Inc. Announces Restructuring Process and the Resignation of 2 Directors
Healthcare & PharmaceuticalCompany Update

Cloud DX Inc. Announces Restructuring Process and the Resignation of 2 Directors

June 6, 2024 8:30 AM

Cloud DX Inc. ("Cloud DX") (TSXV:CDX)(OTCQB:CDXFF) today reports that its wholly-owned subsidiary, Cloud Diagnostics Canada ULC (the "Company"), with the authorization and approval of its board of directors (the "Board"), has filed a Notice of Intention to Make a Proposal ("NOI") pursuant to the provisions of the Bankruptcy and Insolvency Act (Canada). Cloud Diagnostics Canada ULC is a material subsidiary of Cloud DX Inc, accounting for most of...

Read more
Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food & Drug Administration for START Pilot Program
Healthcare & PharmaceuticalRegulatory

Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food & Drug Administration for START Pilot Program

June 6, 2024 7:00 AM

CAMBRIDGE, MA / ACCESSWIRE / June 6, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has selected mRNA-3705 for the Support for Clinical Trials Advancing Rare Disease Therapeutics (START) pilot program. mRNA-3705 is an investigational therapeutic for methylmalonic acidemia (MMA) due to methylmalonic-CoA mutase (MUT) deficiency."We are excited about this opportunity and proud that our...

Read more
Theralase(R) Successfully Destroys Lung Cancer
Healthcare & PharmaceuticalCompany Update

Theralase(R) Successfully Destroys Lung Cancer

June 6, 2024 7:00 AM

Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF) is a clinical stage pharmaceutical company that is dedicated to the research and development of light and/or radiation activated small molecules for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that it's lead compound, RuvidarTM, combined with transferrin to form the compound Rutherrin®, has been proven...

Read more
Zomedica Announces Presentation of Compelling TRUFORMA(R) Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference
Healthcare & PharmaceuticalCompany Update

Zomedica Announces Presentation of Compelling TRUFORMA(R) Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference

June 6, 2024 6:30 AM

ANN ARBOR, MI / ACCESSWIRE / June 6, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced the presentation of research highlighting the improved diagnostic capabilities of the TRUFORMA® Bulk Acoustic Wave (BAW) platform when evaluating cats for thyroid disease compared to widely utilized...

Read more
Saving $7.4 Million by Working Together
Healthcare & PharmaceuticalDiversity, Equity and Inclusion

Saving $7.4 Million by Working Together

June 5, 2024 3:30 PM

NORTHAMPTON, MA / ACCESSWIRE / June 5, 2024 / CARE"The (VSLA) training showed us how to properly manage our money. We discovered we were wasting money and not working together to find the right solution. This is when I decided that my wife would be the best person to look after the money and organize the family expenses." - Kouakou Koffi MichelCARE's Women for Change model is founded on the Village Savings and Loan Association (VSLA) approach...

Read more
Quest Diagnostics Grows Interest in Sustainability With Healthy NewsWorks Students
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Quest Diagnostics Grows Interest in Sustainability With Healthy NewsWorks Students

June 5, 2024 12:10 PM

NORTHAMPTON, MA / ACCESSWIRE / June 5, 2024 / Quest Diagnostics:Quest Diagnostics Director of Sustainability Karen Braun visited East Norriton Middle School for an interview with Healthy NewsWorks student reporters.A Quest for Health Equity (Q4HE) grantee, Healthy NewsWorks has been empowering elementary and middle school students since 2003 to become researchers, writers, and confident communicators who advance health understanding and literacy...

Read more
STR Behavioral Health Opens New Cedar Creek Campus Providing Mental Health Residential Services in Pennsylvania
Healthcare & PharmaceuticalCompany Update

STR Behavioral Health Opens New Cedar Creek Campus Providing Mental Health Residential Services in Pennsylvania

June 5, 2024 9:30 AM

BRENTWOOD, TN / ACCESSWIRE / June 5, 2024 / Odyssey Behavioral Healthcare, a leading provider of addiction, mental health, and eating disorder treatment, is proud to announce the opening of STR Behavioral Health's Cedar Creek campus. The 30-bed residential treatment facility addresses Pennsylvania's unmet need for superior mental health services and marks a significant milestone in their commitment to enhancing the quality and accessibility of...

Read more
Gilead Sciences: Preserving Fertility in the Face of a Cancer Diagnosis
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Gilead Sciences: Preserving Fertility in the Face of a Cancer Diagnosis

June 5, 2024 9:15 AM

NORTHAMPTON, MA / ACCESSWIRE / June 5, 2024 / Emma was a 28-year-old nursing student when she was diagnosed with triple-negative breast cancer. She had always wanted children and, once she learned that her treatment could affect her fertility, she found herself needing to make a quick family planning decision to pursue in vitro fertilization (IVF) and freeze her eggs."You think that you have time to have all these things happen, and you don't,"...

Read more
Inspire Names Health Tech Leader Brett Kleger as New CEO
Healthcare & PharmaceuticalCompany Update

Inspire Names Health Tech Leader Brett Kleger as New CEO

June 5, 2024 9:00 AM

ARLINGTON, VA / ACCESSWIRE / June 5, 2024 / Inspire, the world's leading online health community and real-world data platform, is pleased to announce the appointment of Brett Kleger as its Chief Executive Officer, effective June 5, 2024. "We are thrilled to welcome Brett to Inspire," said Dan Levine, managing director of Tenfore Holdings and an Inspire Board member. "He is a seasoned and innovative executive who has taken several companies from...

Read more
KindlyMD Becomes First Utah Alternative Medical Treatment Company to Contract Under State's Top Insurance Payors
Healthcare & PharmaceuticalPartnerships

KindlyMD Becomes First Utah Alternative Medical Treatment Company to Contract Under State's Top Insurance Payors

June 5, 2024 9:00 AM

KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced it has received credentialing and is contracted under Utah's top insurance payors, becoming the first alternative medical treatment company in the state to receive this status. Kindly MD,...

Read more
Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT Platform
Healthcare & PharmaceuticalRegulatory

Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT Platform

June 5, 2024 9:00 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, announced today that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for patent application 18/302,247, entitled "Compositions and Methods for RNA Synthesis."The resulting patent will cover the composition of the Company's chemically modified RNA polymerase enzyme branded Linea™ RNAP, with...

Read more
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
Healthcare & PharmaceuticalCompany Update

OncoCyte's Innovative Approach: Potential in Precision Diagnostics

June 5, 2024 8:45 AM

Chronic conditions such as organ transplant rejection and cancer represent significant challenges in modern healthcare, demanding precise diagnostic tools for effective management and treatment. For organ transplant patients, the risk of graft rejection remains a persistent threat, necessitating continuous monitoring to ensure long-term success. Similarly, the complexity of cancer requires advanced diagnostics to tailor treatments to individual...

Read more
Avinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral Business
Healthcare & PharmaceuticalCompany Update

Avinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral Business

June 5, 2024 7:30 AM

Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced that it will increase focus on its coronary artery disease program, where it is developing an innovative new image-guided therapeutic system to address unmet coronary market needs, while reducing the operating costs of...

Read more
How Focused Giving Can Unlock Billions and Catapult Women's Wealth
Healthcare & PharmaceuticalEnvironmental, Social and Governance

How Focused Giving Can Unlock Billions and Catapult Women's Wealth

June 5, 2024 7:15 AM

NORTHAMPTON, MA / ACCESSWIRE / June 5, 2024 / CAREBy Mark MuckerheideOriginally published on World Economic Forum.I'll start with a big statement:Strategic corporate giving, with a relentless focus on return on investment (ROI), can dramatically transform the economic landscape for women globally.Ambitious? Yes. Impossible? No.But first, we must address and close a massive gap. Nearly one billion people worldwide live on less than $2.15 per day....

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?